NDC 0002-8805
Humulin N
Insulin Human
Humulin N is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Human.
| Product ID | 0002-8805_03155cd7-d92b-480b-8a86-087659b6990f |
| NDC | 0002-8805 |
| Product Type | Human Otc Drug |
| Proprietary Name | Humulin N |
| Generic Name | Insulin Human |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2013-11-07 |
| Marketing Category | BLA / NDA |
| Application Number | BLA018781 |
| Labeler Name | Eli Lilly and Company |
| Substance Name | INSULIN HUMAN |
| Active Ingredient Strength | 100 [iU]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0002-8805-59
5 SYRINGE in 1 CARTON (0002-8805-59) > 3 mL in 1 SYRINGE (0002-8805-01)
| Marketing Start Date | 2013-11-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0002-8805-01 [00002880501]
Humulin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA018781 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-11-07 |
NDC 0002-8805-59 [00002880559]
Humulin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA018781 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-11-07 |
NDC 0002-8805-99 [00002880599]
Humulin N INJECTION, SUSPENSION
| Marketing Category | NDA |
| Application Number | NDA018781 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-11-07 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| INSULIN HUMAN | 100 [iU]/mL |
OpenFDA Data
| SPL SET ID: | f6edd793-440b-40c2-96b5-c16133b7a921 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
NDC Crossover Matching brand name "Humulin N" or generic name "Insulin Human"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-0352 | Humulin N | Humulin N |
| 47918-874 | Afrezza | Insulin Human |
| 0002-8215 | Humulin | Insulin human |
| 0002-8315 | Humulin | Insulin human |
| 0002-8501 | Humulin | Insulin human |
| 0002-8715 | Humulin | Insulin human |
| 0002-8803 | Humulin | Insulin human |
| 0002-8805 | Humulin | Insulin human |
| 0002-8824 | Humulin | Insulin human |
| 0338-0126 | MYXREDLIN | insulin human |
Trademark Results [Humulin]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HUMULIN 75773392 2345798 Live/Registered |
Eli Lilly and Company 1999-08-11 |
 HUMULIN 75253619 not registered Dead/Abandoned |
Eli Lilly and Company 1997-03-07 |
 HUMULIN 73303147 1201754 Live/Registered |
Eli Lilly and Company 1981-03-27 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.